XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Cash Flows From Operating Activities:    
Net loss $ (431,438) $ (1,422,942)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation and intangible asset amortization expense 7,500 8,556
Share-based compensation 147,094 92,517
Provision for doubtful accounts (1,705) (22,168)
Provision for excess and obsolete inventory 33,638 3,676
Loss on disposal of assets 100 5,499
Amortization of operating lease ROU asset 26,325 25,433
Changes in operating assets and liabilities:    
Accounts receivable (57,420) 10,610
Inventory (126,360) (631,269)
Prepaid expenses and other 1,018,785 (551,261)
Accounts payable and accrued liabilities (43,124) 43,438
Deferred revenue (3,235,970) 2,645,579
Operating lease liability, net (26,662) (14,811)
Net cash provided by (used in) operating activities (2,689,237) 192,857
Cash Flows From Investing Activities    
Purchases of property and equipment (13,948)
Proceeds from the sale of property and equipment 200
Net cash provided by (used in) investing activities 200 (13,948)
Cash Flows From Financing Activities    
Payment of dividends on series B preferred stock (35,984)
Redemption of series B preferred stock (1,980,000)
Net cash proceeds on sale of common stock and warrants, net of expenses 21,711,131
Net cash provided by financing activities 19,695,147
Net change in cash and cash equivalents (2,689,037) 19,874,056
Cash and cash equivalents, beginning of period 18,637,114 2,159,608
Cash and cash equivalents, end of period 15,948,077 22,033,664
Supplemental cash flow information:    
Interest paid
Income taxes paid
Non-cash investing and financing activities:    
Conversion of series B preferred stock 1,980,000
Deemed dividend on series B preferred stock arising on down round 439,999
Options issued for accrued equity compensation liability $ 89,970